HIV/AIDS

Taking stock of existing barriers to sexual and reproductive health of girls and women in SSA and how collaboration and innovation can help shape the future

Retrieved on: 
Wednesday, April 10, 2024
Tiko, CAPE, Government, Learning, UNFPA, Non-governmental organization, Agility, HIV, United, Ageing, United Nations, Shattered Dreams, Economic development, Development impact bond, Private sector, Death, Pregnancy, Adolescence, STI, Woman, Social stigma, Senior counsel, NEWS, Feedback, Health, HIV/AIDS, Tech, Birth control

For years, women and girls have been failed by a fragmented, under-resourced health system that is not built to meet their sexual and reproductive health needs.

Key Points: 
  • For years, women and girls have been failed by a fragmented, under-resourced health system that is not built to meet their sexual and reproductive health needs.
  • Coupled with HIV, complications during pregnancy and childbirth are the leading cause of death for young women aged 15-19 years.
  • "Tiko" which provides access to free reproductive health services that can change the course of many lives offering youth-friendly care and comprehensive information.
  • Achieving universal access to sexual and reproductive health and rights by 2030 will require close collaboration by stakeholders in developing innovative solutions that can dismantle barriers to access among women and girls.

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Retrieved on: 
Wednesday, April 3, 2024
Ventricular septal defect, DCN, Disease, HIV, Patient, CTD, Connective tissue disease, Death, Parkinson's disease, Imatinib, IND, Pulmonary hypertension, Woman, Therapy, Heart, Safety, Division, WHO, HIV/AIDS, Stomach, PAH, FDA, Blood, Food, Pharmaceutical industry

The meeting will be held on April 5, 2024, with meeting results to be reported following receipt of the formal meeting minutes.

Key Points: 
  • The meeting will be held on April 5, 2024, with meeting results to be reported following receipt of the formal meeting minutes.
  • “Following our pre-NDA discussion with the FDA related to the path to approval for IkT-001Pro in up to 11 blood and stomach cancers in January, we requested an additional FDA meeting with the Division of Cardiology and Nephrology to discuss Pro as a treatment for Pulmonary Arterial Hypertension,” said Dr. Milton Werner, President and Chief Executive Officer of Inhibikase.
  • “PAH is a rare condition that primarily afflicts women between the ages of 30 and 60 and can lead to premature heart failure and death.
  • We believe that Pro may be a be a safer and better tolerated therapeutic option for imatinib treatment in PAH.

COVID-19 Virus Can Persist in the Body More Than a Year after Infection

Retrieved on: 
Tuesday, April 9, 2024
Research, Infection, Harvard Medical School, HIV/AIDS, Conditional sentence, COVID, UCSF, Biomedical Research, Coronavirus, UC, Nature, University, SARS-CoV-2, MD, Volunteering, Life, Protein, Consortium, Lymph, Division, Viral, Government, Vaccine

MEDFORD, Mass., April 8, 2024 /PRNewswire/ -- Research published today in Lancet Infectious Diseases and supported by PolyBio Research Foundation provides the strongest evidence yet that the COVID virus can persist for months or years after infection. The findings, published by a UC San Francisco/Harvard Medical School team, found that proteins created by the virus were still present for up to 14 months in a quarter of people tested. This demonstrates SARS-CoV-2 viral persistence as an urgent area of research underlying a breadth of chronic disease after COVID. 

Key Points: 
  • "The fact that every new SARS-CoV-2 infection has the potential to become chronic is perhaps the single most concerning aspect of this virus," says Dr. Amy Proal, President of PolyBio.
  • "We have compelling data that viral persistence is much more common than recognized which could have major health implications."
  • The researchers analyzed blood samples from 171 people who had been infected with the virus.
  • These findings greatly bolster evidence that the coronavirus can linger in tissue and organs, even after recovery from acute infection.

Illinois Lottery Reports Half-Year Results

Retrieved on: 
Tuesday, March 19, 2024
DREAM, Homelessness, HIV/AIDS, BP, General counsel, Education, Lotto, Multiple sclerosis, Special Olympics, Olympic Games, Illinois State Lottery, Breast cancer, UNCF, Fiscal year

CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) -- The Illinois Lottery today announced its results for the first six months of the 2024 fiscal year, in which the Lottery has generated $1.9 billion in sales leading to estimated returns to the State of Illinois of $456 million so far.

Key Points: 
  • CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) -- The Illinois Lottery today announced its results for the first six months of the 2024 fiscal year, in which the Lottery has generated $1.9 billion in sales leading to estimated returns to the State of Illinois of $456 million so far.
  • Additionally, the Illinois Lottery raised over $4.1 million in the first half of the 2024 fiscal year for good causes in Illinois.
  • The Lottery has contributed more than $24 billion in revenue to educational funding in Illinois,” said Harold Mays, Illinois Lottery Director.
  • During the fiscal period, the Illinois Lottery launched its first-ever $50 Instant Ticket.

Protesters Keep Heat on Greedy Gilead over Price Gouging

Retrieved on: 
Wednesday, March 13, 2024
Men, General Health, Pharmaceutical, Consumer, State, Local, Infectious Diseases, Public Policy, Health Insurance, Women, AIDS, Health, Government, HIV/AIDS, Conference, AIDS Healthcare Foundation, HIV, Gilead Sciences, AHF, Multimedia, Pharmacy, Pharmaceutical industry

HIV/AIDS advocates from AIDS Healthcare Foundation (AHF) will continue their campaign of protests targeting Gilead Sciences over the company’s ongoing efforts to rack up exorbitant profits while restricting access to its lifesaving medications.

Key Points: 
  • HIV/AIDS advocates from AIDS Healthcare Foundation (AHF) will continue their campaign of protests targeting Gilead Sciences over the company’s ongoing efforts to rack up exorbitant profits while restricting access to its lifesaving medications.
  • Protesters will gather Wednesday in front of the Loews Miami Beach Hotel where executives from Gilead will be presenting at the Barclays Annual Global Health Conference.
  • View the full release here: https://www.businesswire.com/news/home/20240312694416/en/
    The group hosted a similar protest rally targeting Gilead at the Fontainebleau Miami Beach Hotel Tuesday while company executives presented during the Leerink Partners Biopharma Conference.
  • HIV/AIDS activists are also specifically targeting Gilead CEO Daniel O’Day over his February appointment as board chair for PhRMA (Pharmaceutical Research and Manufacturers of America), the cutthroat trade group representing companies in the pharmaceutical industry in the United States.

AHF Keeps Pressure on ‘Greedy Gilead’ Over Price Gouging

Retrieved on: 
Monday, March 11, 2024
Pharmaceutical, Philanthropy, Infectious Diseases, Healthcare Reform, Social Activism, Public Policy, Advocacy Group Opinion, Foundation, Communications, AIDS, Health, Government, HIV/AIDS, Conference, AIDS Healthcare Foundation, HIV, Gilead Sciences, City, AHF, Pharmacy, Pharmaceutical industry

AIDS Healthcare Foundation (AHF) advocates will rally at the Fontainebleau Miami Beach Hotel Tuesday to protest Gilead Sciences ’ ongoing efforts to rack up exorbitant profits while restricting access to lifesaving medications.

Key Points: 
  • AIDS Healthcare Foundation (AHF) advocates will rally at the Fontainebleau Miami Beach Hotel Tuesday to protest Gilead Sciences ’ ongoing efforts to rack up exorbitant profits while restricting access to lifesaving medications.
  • AHF’s sustained protests against the drug maker continue as Gilead faces legal action over its keeping safer HIV medications off the market to maximize profits.
  • “It is so sadly apropos that Gilead CEO Daniel O’Day — the poster child for PhRMA greed — also now sits atop PhRMA, the undisputed fortress of greed,” said Michael Weinstein, AHF president and cofounder.
  • Since 2021, AHF has been taking on Gilead and CEO Daniel O’Day, holding more than two dozen protests in multiple cities, including Washington, DC, Miami, Boston, and Foster City, CA at Gilead’s corporate headquarters.

Housing Works Cannabis Co Partners with Think Coffee to Amplify Good Works and Build Community

Retrieved on: 
Thursday, March 28, 2024
HIV/AIDS, Homelessness, Tea, Housing Works, Partnership, Coffee, Social responsibility, Cannabis, Plant, Housing, Works, Metropolitan Pavilion, Drug

NEW YORK, March 28, 2024 /PRNewswire/ -- Housing Works Cannabis Co (HWCC), New York's first adult-use cannabis dispensary opened by esteemed parent organization Housing Works in 2022, today announced a partnership with the beloved New York City-based Think Coffee.

Key Points: 
  • NEW YORK, March 28, 2024 /PRNewswire/ -- Housing Works Cannabis Co (HWCC), New York's first adult-use cannabis dispensary opened by esteemed parent organization Housing Works in 2022, today announced a partnership with the beloved New York City-based Think Coffee .
  • "Housing Works and Think Coffee share values of social responsibility, community support and sustainability—and this partnership is the perfect demonstration of that," said Sasha Nutgent, HWCC's Director of Retail.
  • On April 26-27, the Think Coffee cart will be on-site at Housing Works' annual Design on a Dime event at the Metropolitan Pavilion.
  • "I moved to New York City in 1990, the year that Housing Works was founded," said Jason Scherr, Owner & CEO of Think Coffee.

Fiocruz and Caring Cross Announce Collaboration Agreement to Enable Access to Affordable CAR-T Therapy in Brazil and Latin America

Retrieved on: 
Tuesday, March 26, 2024
Organization, HIV, Patient, DSM-IV codes, Knowledge, Ministry of Health, Leukemia, Infection, HIV/AIDS, Ministry, Lymphoma

RIO DE JANEIRO and GAITHERSBURG, Md., March 26, 2024 /PRNewswire/ -- Fundação Oswaldo Cruz (Fiocruz), a foundation from the Brazilian government's Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic diseases in Brazil, including CAR-T cell therapies for leukemia, lymphoma, and HIV infection.

Key Points: 
  • CAR-T cell therapies represent a revolutionary treatment, harnessing the body's own immune cells to precisely target and destroy infected cells.
  • Caring Cross has developed manufacturing processes that significantly decreases the material cost of manufacturing CAR-T cell therapy products.
  • The agreement with Fiocruz, exclusive to Brazil and Latin America, will not only enable affordable access of CAR-T cell therapies for the Brazilian public health system, but will allow access of critical materials and training needed to manufacture CAR-T cells for other organizations in Brazil and Latin America.
  • "Our collaboration with Fiocruz marks a significant step forward in making CAR-T cell therapies more accessible in Brazil and Latin America," said Boro Dropulić, Ph.D., Executive Director of Caring Cross.

CGTN: China advances battle against tuberculosis

Retrieved on: 
Sunday, March 24, 2024
Diagnosis, Control, China Media Group, Disease, HIV/AIDS, Tuberculosis, World Tuberculosis Day, United, Patient, Research, United Nations, Hope, Volunteering, Health education, CDC, Vaccination, WHO, Media Group, TB, Parent, UN, Pharmaceutical industry

According to the World Health Organization's (WHO) Global Tuberculosis Report 2023, in 2022, there were more than 10.6 million cases of active TB globally, with 1.3 million deaths.

Key Points: 
  • According to the World Health Organization's (WHO) Global Tuberculosis Report 2023, in 2022, there were more than 10.6 million cases of active TB globally, with 1.3 million deaths.
  • The Chinese government attaches great importance to TB prevention and treatment and has incorporated it into the Healthy China strategy.
  • China also attaches great importance to the development of young volunteers and actively encourages public voluntary actions for TB prevention and control.
  • Over the past 10 years, the number of volunteers in China has increased to over 1 million, more than half of whom are young people.

CGTN: China advances battle against tuberculosis

Retrieved on: 
Sunday, March 24, 2024
Diagnosis, Control, China Media Group, Disease, HIV/AIDS, Tuberculosis, World Tuberculosis Day, United, Patient, Research, United Nations, Hope, Volunteering, Health education, CDC, Vaccination, WHO, Media Group, TB, Parent, UN, Pharmaceutical industry

According to the World Health Organization's (WHO) Global Tuberculosis Report 2023, in 2022, there were more than 10.6 million cases of active TB globally, with 1.3 million deaths.

Key Points: 
  • According to the World Health Organization's (WHO) Global Tuberculosis Report 2023, in 2022, there were more than 10.6 million cases of active TB globally, with 1.3 million deaths.
  • The Chinese government attaches great importance to TB prevention and treatment and has incorporated it into the Healthy China strategy.
  • China also attaches great importance to the development of young volunteers and actively encourages public voluntary actions for TB prevention and control.
  • Over the past 10 years, the number of volunteers in China has increased to over 1 million, more than half of whom are young people.